GlassScriptPhysician profile
Seth M Brown
NPI 1346660958
$8,504.47
in general payments reported to CMS, 2019-2025
19 companies · $1,101 in 2025
The $1,101 reported for 2025 was more than what a typical Vascular & Interventional Radiology provider received nationally (typical 2025 total: $537).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $97.63 · 2020: $1,093 · 2021: $3,127 · 2022: $1,065 · 2023: $1,151 · 2024: $871 · 2025: $1,101.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,844 · Travel and Lodging: $240 · Education: $37.85.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,844.28 |
| Travel and Lodging | $240.35 |
| Education | $37.85 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Penumbra, INC. | $4,493.15 | 2021-2025 | Indigo System, Ruby Coil |
| Boston Scientific Corporation | $1,656.32 | 2019-2025 | Ranger, General - Embolics, Obsidio |
| Stryker Corporation | $565.47 | 2021-2025 | Ct Thrombectomy System Kit, Flowtriever Catheter, S, Flowtriever |
| Medtronic, INC. | $551.98 | 2023 | Ellipsys Vascular Access System |
| Inari Medical, INC. | $545.99 | 2022-2025 | Flowtriever Catheter, S, Ct Thrombectomy System Kit |
| Bard Peripheral Vascular, INC. | $136.79 | 2022-2023 | Venovo |
| Terumo Medical Corporation | $106.24 | 2020 | |
| Biocompatibles, INC. | $68.36 | 2019 | |
| Convatec INC. | $67.80 | 2024-2025 | |
| W. L. Gore & Associates, INC. | $65.64 | 2021-2022 | |
| Argon Medical Devices, INC. | $44.41 | 2020 | |
| Bsn Medical INC | $42.58 | 2024 | |
| Angiodynamics, INC. | $33.31 | 2022-2023 | Bioflo |
| Organogenesis INC. | $27.65 | 2024 | |
| Abbott Laboratories | $23.27 | 2022 |
Show all 19 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Ethicon US, LLC | $21.22 | 2022 | |
| Reprise Biomedical, INC. | $21.16 | 2024 | Miro3d |
| Cardiovascular Systems INC. | $18.63 | 2021 | |
| Paratek Pharmaceuticals, INC. | $14.50 | 2024 | Nuzyra |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Seth Brown listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.